{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:16:52Z","timestamp":1740140212150,"version":"3.37.3"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Clinical Research Priority Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,2]]},"DOI":"10.1093\/neuonc\/noad131","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T09:30:33Z","timestamp":1690795833000},"page":"2072-2073","source":"Crossref","is-referenced-by-count":0,"title":["Chimeric antigen receptors in the brain: Can we tackle glioblastoma with engineered NK cells?"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3897-214X","authenticated-orcid":false,"given":"Patrick","family":"Roth","sequence":"first","affiliation":[{"name":"University Hospital Zurich and University of Zurich, Department of Neurology and Brain Tumor Center , Zurich , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"issue":"7","key":"2023110711210103500_CIT0001","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1158\/1078-0432.CCR-18-1625","article-title":"Immunotherapy for glioblastoma: Adoptive T-cell strategies","volume":"25","author":"Choi","year":"2019","journal-title":"Clin Cancer Res."},{"issue":"3","key":"2023110711210103500_CIT0002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1158\/1078-0432.CCR-17-2871","article-title":"CAR T-cell therapies in glioblastoma: A first look","volume":"24","author":"Migliorini","year":"2018","journal-title":"Clin Cancer Res."},{"issue":"7906","key":"2023110711210103500_CIT0003","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-022-04585-5","article-title":"CAR T cell killing requires the IFNgammaR pathway in solid but not liquid tumours","volume":"604","author":"Larson","year":"2022","journal-title":"Nature."},{"issue":"11","key":"2023110711210103500_CIT0004","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/neuonc\/noad087","article-title":"Intracranial injection of NK cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma","volume":"25","author":"Burger","year":"2023","journal-title":"Neuro Oncol"},{"issue":"1","key":"2023110711210103500_CIT0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41698-023-00356-1","article-title":"Advances in NK cell therapy for brain tumors","volume":"7","author":"Fares","year":"2023","journal-title":"npj Precis Oncol."},{"issue":"399","key":"2023110711210103500_CIT0006","doi-asserted-by":"crossref","first-page":"eaaa0984","DOI":"10.1126\/scitranslmed.aaa0984","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","volume":"9","author":"O\u2019Rourke","year":"2017","journal-title":"Sci Transl Med."},{"issue":"4","key":"2023110711210103500_CIT0007","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1158\/1078-0432.CCR-17-1766","article-title":"NKG2D-dependent antitumor effects of chemotherapy and radiotherapy against glioblastoma","volume":"24","author":"Weiss","year":"2018","journal-title":"Clin Cancer Res."},{"issue":"2","key":"2023110711210103500_CIT0008","doi-asserted-by":"crossref","first-page":"e20192203","DOI":"10.1084\/jem.20192203","article-title":"Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression","volume":"218","author":"Lanitis","year":"2021","journal-title":"J Exp Med."},{"issue":"11","key":"2023110711210103500_CIT0009","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/neuonc\/noad108","article-title":"Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma","volume":"25","author":"Hansch","year":"2023","journal-title":"Neuro Oncol"},{"issue":"533","key":"2023110711210103500_CIT0010","doi-asserted-by":"crossref","first-page":"eaaw2672","DOI":"10.1126\/scitranslmed.aaw2672","article-title":"Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma","volume":"12","author":"Wang","year":"2020","journal-title":"Sci Transl Med."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noad131\/51200017\/noad131.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/11\/2072\/52763414\/noad131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/11\/2072\/52763414\/noad131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T01:02:10Z","timestamp":1702861330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/25\/11\/2072\/7233846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":10,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,7,31]]},"published-print":{"date-parts":[[2023,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad131","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"type":"print","value":"1522-8517"},{"type":"electronic","value":"1523-5866"}],"subject":[],"published-other":{"date-parts":[[2023,11,1]]},"published":{"date-parts":[[2023,7,31]]}}}